Octagon Capital Advisors LP

Q4 2024 13F Holdings

  • Location
    new york, NY
  • Num holdings

    33

  • Value ($000)

    $607,701

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001839435
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
APLS
APLS

APELLIS PHARMACEUTICALS INC

COM
03753U106
$95.95M
16 %

3,006,980

AVBP
AVBP

ARRIVENT BIOPHARMA INC

COM
04272N102
$54.86M
9 %

2,059,387

DNTH
DNTH

DIANTHUS THERAPEUTICS INC

COM
252828108
$46.00M
8 %

2,110,167

CNTA
CNTA

CENTESSA PHARMACEUTICALS PLC

SPONSORED ADS
152309100
$33.38M
6 %

1,993,052

VRNA
VRNA

VERONA PHARMA PLC

SPONSORED ADS
925050106
$26.53M
4 %

571,264

NUVB
NUVB

NUVATION BIO INC

COM CL A
67080N101
$24.48M
4 %

9,202,907

INSM
INSM

INSMED INC

COM PAR
457669307
$22.92M
4 %

332,000

COGT
COGT

COGENT BIOSCIENCES INC

COM
19240Q201
$21.55M
4 %

2,763,000

SRRK
SRRK

SCHOLAR ROCK HLDG CORP

COM
80706P103
$21.09M
4 %

488,000

MMED
MMED

MIND MEDICINE MINDMED INC

COM NEW
60255C885
$21.01M
4 %

3,018,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 33